Article summary
At ICPR 2026 at the historic city ofin Haarlem in the Netherlands, the companies racing to turn psychedelics into approved medicines were nowhere to be found, leaving a hall full of researchers, clinicians, and one reimbursement-obsessed reporter to sit with the unglamorous question of how these treatments will ever actually reach a patient. The post Approval Is Not Access: A Postcard From Psychedelic Europe first appeared on Lucid News. The post Approval Is Not Access: A Postcard From Psychedelic Europe appeared first on Lucid News.
Continue to the original publication for the complete article.